Literature DB >> 15095471

Cost of fetal alcohol spectrum disorders.

Chuck Lupton1, Larry Burd, Rick Harwood.   

Abstract

Fetal alcohol syndrome (FAS) is a common identifiable teratogenic cause of mental retardation, neurological deficit, mental disorders, and developmental disabilities. Accurate estimates of the cost of care for persons with FAS are essential for appropriate funding of health care, developmental disabilities services, special education, and other service systems, as well as prioritizing funding of public health prevention efforts. The cost of care for individuals with FAS can be conceptualized as the annual cost of care for one person or a population, or as the lifetime cost of care for an individual. Annual cost estimates for the United States range from $75 million in 1984 to $4.0 billion in 1998. Estimates of lifetime cost vary from $596,000 in 1980 to $1.4 million in 1988. After adjustments for changes in inflation and population, 2002 estimates of total annual cost and lifetime cost are higher. FAS is increasingly being recognized as a large public health problem with high potential for the prevention of future cases and for the prevention of excess disability and premature mortality in persons who are affected. Each day, from 6-22 infants with FAS are born in the United States, and as many as 87-103 more are born with other impairments resulting from prenatal alcohol exposure. Updated and improved cost data on FAS should be a research priority. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15095471     DOI: 10.1002/ajmg.c.30015

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  100 in total

Review 1.  Mechanisms of ethanol-induced death of cerebellar granule cells.

Authors:  Jia Luo
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

2.  Preconception markers of dual risk for alcohol and smoking exposed pregnancy: tools for primary prevention.

Authors:  Karen S Ingersoll; Jennifer E Hettema; Karen L Cropsey; Justin P Jackson
Journal:  J Womens Health (Larchmt)       Date:  2011-08-12       Impact factor: 2.681

Review 3.  Fetal Alcohol Spectrum Disorders: A Review of the Neurobehavioral Deficits Associated With Prenatal Alcohol Exposure.

Authors:  Sarah N Mattson; Gemma A Bernes; Lauren R Doyle
Journal:  Alcohol Clin Exp Res       Date:  2019-05-02       Impact factor: 3.455

4.  The effects of postnatal alcohol exposure and galantamine on the context pre-exposure facilitation effect and acetylcholine efflux using in vivo microdialysis.

Authors:  Amy E Perkins; Jim R Fadel; Sandra J Kelly
Journal:  Alcohol       Date:  2015-02-25       Impact factor: 2.405

5.  Sobering thoughts: town Hall meetings on fetal alcohol spectrum disorders.

Authors:  Doreen Major Ryan; Doreen M Bonnett; Callie B Gass
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

6.  Developmental Trajectories for Visuo-Spatial Attention are Altered by Prenatal Alcohol Exposure: A Longitudinal FMRI Study.

Authors:  P Gautam; S C Nuñez; K L Narr; S N Mattson; P A May; C M Adnams; E P Riley; K L Jones; E C Kan; E R Sowell
Journal:  Cereb Cortex       Date:  2014-08-04       Impact factor: 5.357

7.  Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure.

Authors:  B Lewis; K A Wellmann; S Barron
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

Review 8.  Autophagy and ethanol neurotoxicity.

Authors:  Jia Luo
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

9.  Inconsistent report of pre-pregnancy-recognition alcohol use by Latinas.

Authors:  Suzanne C Hughes; Christina D Chambers; Nada Kassem; Dennis R Wahlgren; Sarah Larson; Edward P Riley; Melbourne F Hovell
Journal:  Matern Child Health J       Date:  2008-09-23

10.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.